gamida cell stock target price

The average Gamida Cell stock price prediction forecasts a. Gamida Cell Ltd 165 009 490 3rd Party Ad.


Finance Watch Days Of Reckoning As Biopharma Valuations Fundraising Opportunities Fluctuate Scrip

Not an offer or recommendation by Stocktwits.

. Price Target Based on short-term price targets offered by five analysts the average price target for Gamida Cell comes to 1360. BOSTON October 10 2022. GMDA was reported by Needham on September 29 2022The analyst firm set a price target for 900 expecting GMDA to rise to.

Analysts consensus targets ratings and recommendations Nasdaq. The 4 analysts offering price forecasts for Gamida Cell have a median target of 1250 with a high estimate of 1500 and a low estimate of 900. The current analyst and expert consensus on Gamida Cell is Buy with 0 strong sell and 4 strong buy opinions.

GMDA stock quote history news and other vital information to help you with your stock trading and investing. Get a real-time Gamida Cell Ltd. Find the latest Gamida Cell Ltd.

GMDA stock price quote with breaking news financials statistics charts and more. According to 12 stock analysts the average 12-month stock price forecast for Gamida Cell stock is 1428 which predicts an increase of 77073. 2 Wall Street analysts that have issued a 1 year GMDA price target the average GMDA price target is 1200.

The lowest target is. Raising target price to 13400AGILENT. GMDA Stock Price Prediction.

The current projected Gamida Cell target price consensus is 146 with 5 analyst. The 5 analysts offering 12-month price forecasts for Gamida Cell Ltd have a median target of 1500 with a high estimate of 2200 and a low estimate of 700. Analyst estimates including GMDA earnings per share estimates and analyst recommendations.

Piper Sandler raised their price target on shares of Gamida Cell from 600 to 800 in a research report on Monday August 15th. Based on 5 Wall Street analysts offering 12 month price targets for Gamida Cell in the last 3 months. GMDA Complete Gamida Cell Ltd.

GMDA stock quote history news and other vital information to help you with your stock trading and investing. 813a Oracle stock price target raised to 120 from 110 at Deutsche Bank. Gamida Cell Ltd NASDAQ Updated Oct 19 2022 929 PM.

View real-time stock prices and stock quotes for a full financial overview. Find Gamida Cell Smart Score expert sentiment charts stats. In terms of how GAMIDA CELL LTD fares relative to all US stocks note that its average analyst price target is greater than 148 of that group.

The forecasts range from a low of 800 to a high of 2200. Six investment analysts have rated the stock with. Get a real-time Gamida Cell Ltd.

Gamida Cell NASDAQGMDA Get Rating had its price target decreased by Needham Company LLC from 1200 to 900 in a research report released on Thursday. Gamida Cell started at buy with. The latest price target for.

The median estimate represents a 1312. Stock news by MarketWatch. Find the latest Gamida Cell Ltd.

Get a free in-depth analysis of Gamida Cell GMDA stock. The average price target is 1575 with a high forecast of. In the context of stocks in the small market cap.

GAMIDA CELL LTD.


Sec Filing Investors Gamida Cell Ltd


S002295x7 Graphic15 Jpg


Preview Gamida Cell S Earnings Gamida Cell Nasdaq Gmda Benzinga


Gmda Stock Price And Chart Nasdaq Gmda Tradingview


Gamida Cell Ltd Gmda Stock Price News Quote History Yahoo Finance


Gmda Current Report Filing 8 K


Gamida Cell Ltd Gmda Stock Price Quote News Stock Analysis


Is Gamida Cell Ltd Gmda Stock At The Top Of The Biotechnology Industry


Gamida Cell Nasdaq Gmda Price Target Cut To 9 00 Etf Daily News


Gamida Cell Stock Gearing Up For Fda Approval Nasdaq Gmda Seeking Alpha


Gamida Cell Ltd Gmda Stock Price Quote News Stock Analysis


Gamida Cell Ltd Gmda Stock Price News Quote History Yahoo Finance


5 Hot Penny Stocks To Watch With Premarket Momentum News


Innovators Take Cover As Market Bubble Bursts Nature Biotechnology


Company Graphite Bio


Gamida Cell Ltd Gmda Stock Price Quote News Stock Analysis


Novartis Backed Gamida Hits Goal In Phase 3 Cancer Trial Fierce Biotech


Gamida Cell Stock Gearing Up For Fda Approval Nasdaq Gmda Seeking Alpha


Analysts Have Given Gamida Cell Ltd Nasdaq Gmda An Average Recommendation Of Buy Best Stocks

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel